LN6081448
Analysis standard reagent , 134605-64-4
Synonym(s):
1-(Allyloxycarbonyl)-1-methylethyl 2-chloro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzoate
CAS NO.:134605-64-4
Empirical Formula: C20H18ClF3N2O6
Molecular Weight: 474.81
MDL number: MFCD05865280
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB918.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 539.4±60.0 °C(Predicted) |
| Density | 1.406±0.06 g/cm3(Predicted) |
| vapor pressure | 0Pa at 25℃ |
| storage temp. | 0-6°C |
| pka | -4.21±0.40(Predicted) |
| Water Solubility | 10mg/L at 25℃ |
| Major Application | agriculture environmental |
| InChI | 1S/C20H18ClF3N2O6/c1-5-8-31-17(29)19(2,3)32-16(28)12-9-11(6-7-13(12)21)26-15(27)10-14(20(22,23)24)25(4)18(26)30/h5-7,9-10H,1,8H2,2-4H3 |
| InChIKey | JEDYYFXHPAIBGR-UHFFFAOYSA-N |
| SMILES | CN1C(=O)N(C(=O)C=C1C(F)(F)F)c2ccc(Cl)c(c2)C(=O)OC(C)(C)C(=O)OCC=C |
| LogP | 3.19 at 25℃ |
| EPA Substance Registry System | Butafenacil (134605-64-4) |
Description and Uses
Butafenacil is a herbicide used to control annual and perennial broadleaved weeds. Iit has a moderate aqueous solubility and a low volatility. It is not usually persistent in soil systems but may be moderately persistent in aquatic systems, depending on local conditions. It is moderately toxic to honeybees and most aquatic species but less so to birds and earthworms. It has a low oral mammalian toxicity and is an irritant,
Butafenacil is a uracil based herbicide that function via the inhibition of protoporphyrinogen oxidase.
Safety
| Symbol(GHS) | ![]() ![]() GHS08,GHS09 |
| Signal word | Warning |
| Hazard statements | H373-H410 |
| Precautionary statements | P260-P273-P314-P391-P501 |
| target organs | Liver |
| PPE | Eyeshields, Gloves |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN3077 9/PG 3 |
| WGK Germany | 2 |
| Storage Class | 13 - Non Combustible Solids |
| Hazard Classifications | Aquatic Acute 1 Aquatic Chronic 1 STOT RE 2 Oral |
| REACH Registrations | Inactive |








